Ursodeoxycholic Acid API
Mechanism of Action
Ursodeoxycholic acid is a bile acid that reduces the hepatic synthesis of cholesterol and increases the intestinal absorption of dietary fats. It improves liver function by promoting bile flow and reducing cholesterol crystallization in bile, making it effective in treating cholestatic liver diseases, including primary biliary cholangitis.
Indication
Indicated for the treatment of primary biliary cholangitis and for the dissolution of cholesterol gallstones in patients who are not surgical candidates.
Ursodeoxycholic Acid API for pharmaceutical buyers
Valence Labs supplies Ursodeoxycholic Acid API, also known as UDCA API, for sourcing teams that need a clear product discussion around specifications, pharmacopoeial standards, documentation status, packaging, and export supply requirements.
Technical snapshot
- Product: Ursodeoxycholic Acid API
- Common abbreviation: UDCA API
- CAS No. 128-13-2
- Listed standards: IP, USP, EP, and BP
- Therapeutic category: cholelithiasis agent
- Status: commercialised; DMF availability noted in the Valence Labs portfolio
Buyer documentation focus
UDCA API inquiries usually require alignment on specification, pharmacopoeial standard, impurity expectations, documentation status, sample requirements, packaging, target market, and delivery timeline.
For a faster response, share the required market, expected quantity, documentation need, and current development or commercial stage.
Therapeutic context
Ursodeoxycholic Acid is a bile acid used in finished pharmaceutical products related to cholestatic liver disease and cholesterol gallstone dissolution. Valence Labs’ role is API supply and documentation support for qualified pharmaceutical customers.
Related Valence capabilities
UDCA API FAQ
What is the CAS number for Ursodeoxycholic Acid?
The CAS number listed for Ursodeoxycholic Acid is 128-13-2.
Which standards are listed by Valence Labs?
Valence Labs lists UDCA API with IP, USP, EP, and BP standards.
How should buyers start an inquiry?
Send the target market, quantity, required documentation, specification expectations, and timeline through the contact form.


